DR

Donna Rill

Chief Technology Officer

Triumvira Immunologics

Spring, Texas


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Triumvira Immunologics
Industry
research
Employees
30.0
Seniority
C suite
Annual Revenue
8400000.0
Total Funding
124742729.0
Latest Funding
Series A

Technologies

Outlook Google Cloud Hosting BugHerd Vimeo Google Tag Manager WordPress.org Typekit Mobile Friendly reCAPTCHA Bootstrap Framework YouTube Nginx Viewpoint

Keywords

immunology oncology cell & gene therapy t cell antigen coupler clinical developement partnerships biotechnology research t cell therapy immunotherapy tac technology autologous t cells allogeneic t cells car-t tcr therapy cancer treatment tumor targeting tumor antigen recognition liquid tumors solid tumors clinical trials antigen coupler cell therapy cell manufacturing gamma delta t cells t cell activation immune response enhancement tumor microenvironment side effect reduction anti-tumor response immune system activation tumor cell killing t cell persistence safety profiles preclinical studies pipeline development biotechnology phd research receptor targeting genetic engineering t cell receptor biopharmaceuticals healthcare innovation disease management patient-derived therapy biologic therapies pharmaceutical development clinical efficacy anti-cancer therapies cell culture novel therapeutics treatment paradigms healthcare investment collaborative research healthcare partnerships clinical data hospital & health care health care health wellness & fitness

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans